Trade Novavax NVAX

Novavax live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close change Change (%) Open High Low

Novavax news

2021 May 11, 13:20

US pre-market: selling unabated

2021 May 06, 08:27

Stocks rally as Fed speakers get back on script, earnings support + Bank of England set to raise forecasts

2021 Feb 28, 07:36

Week Ahead: RBA speaks, US NFPs released & OPEC clash

2020 May 26, 08:04

Leg up: stocks make new ground, travel stocks soar

Latest news

Show more
Ghko B 2025 Jun 23, 16:00

IBO stock up 200% today: what’s going on with Impact Biomedical

Stocks
Tommy Yap 2025 Jun 23, 16:00

Morning Note: Mideast Tensions Drive Oil & Gold Volatility; Tesla Rolls Out Robotaxi

Morning Note Commodities Tech
Ghko B 2025 Jun 22, 16:00

Global tensions impacted crypto market: BTC over $100K, Cardano around $0.54

Cryptocurrencies
Frances Wang 2025 Jun 22, 16:00

Stock market reaction to Iran: Dow, S&P 500, Nasdaq set for modest

Stocks
Tommy Yap 2025 Jun 21, 21:00

Week Ahead: Fed Inflation Gauge: Core PCE Price Index in the Spotlight

Forex Indices
Tommy Yap 2025 Jun 19, 16:00

Morning Note: Dollar Climbs on Mideast Tensions; Oil Dips; Accenture Q3

Morning Note USD Indices Commodities
Frances Wang 2025 Jun 18, 16:00

BTCUSD Analysis: Bitcoin Price Dropped Amid Iran-Israel Tensions

Cryptocurrencies
Tommy Yap 2025 Jun 18, 16:00

Morning Note: Stablecoin Boom on Senate Bill; SNB and BoE Rate Decisions Awaited

Morning Note Cryptocurrencies Forex

Info

Spread

0.05

Spread (%)

0.7949 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Tuesday

13:31 - 19:59

Monday

13:31-19:59

Wednesday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

1022030720

Shares Outstanding

161970000

Earnings Date (Next)

2019-05-10

instr__dividend_date

2019-05-10

instr__ex_dividend_date

instr__forward_annual_dividend_rate

0

instr__forward_annual_dividend_yield

0

EPS

2.75

Learn more about this instrument

Novavax Novavax Inc
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments

Latest Education Articles

Show more
Trustpilot